IL164031A - Compositiion having gelling properaties for the prolonged delivery of bioactive substances - Google Patents
Compositiion having gelling properaties for the prolonged delivery of bioactive substancesInfo
- Publication number
- IL164031A IL164031A IL164031A IL16403104A IL164031A IL 164031 A IL164031 A IL 164031A IL 164031 A IL164031 A IL 164031A IL 16403104 A IL16403104 A IL 16403104A IL 164031 A IL164031 A IL 164031A
- Authority
- IL
- Israel
- Prior art keywords
- properaties
- compositiion
- gelling
- bioactive substances
- prolonged delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0203059A FR2837099B1 (fr) | 2002-03-12 | 2002-03-12 | Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives |
| US40572002P | 2002-08-26 | 2002-08-26 | |
| PCT/FR2003/000797 WO2003075885A1 (fr) | 2002-03-12 | 2003-03-12 | Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL164031A true IL164031A (en) | 2010-11-30 |
Family
ID=27806677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL164031A IL164031A (en) | 2002-03-12 | 2004-09-12 | Compositiion having gelling properaties for the prolonged delivery of bioactive substances |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7691408B2 (fr) |
| EP (1) | EP1485066B1 (fr) |
| JP (1) | JP2005528352A (fr) |
| CN (1) | CN100584314C (fr) |
| AU (1) | AU2003227827B2 (fr) |
| BR (1) | BRPI0308360B8 (fr) |
| CA (1) | CA2478825C (fr) |
| HK (1) | HK1071704A1 (fr) |
| IL (1) | IL164031A (fr) |
| MX (1) | MXPA04008906A (fr) |
| NO (1) | NO339426B1 (fr) |
| NZ (1) | NZ535270A (fr) |
| WO (1) | WO2003075885A1 (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005528352A (ja) | 2002-03-12 | 2005-09-22 | エチファルム | 生体活性物質の持続的放出に用いるためのゲル化特性を有する組成物 |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| BRPI0608152A2 (pt) * | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
| US20070015689A1 (en) * | 2005-06-23 | 2007-01-18 | Alza Corporation | Complexation of metal ions with polypeptides |
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| ATE553659T1 (de) * | 2006-07-24 | 2012-05-15 | Unilever Nv | Ausgangsstoff für ein getränk |
| ES2562878T3 (es) | 2007-05-25 | 2016-03-08 | Indivior Uk Limited | Formulaciones de liberación sostenida de compuestos de risperidona |
| FR2926996B1 (fr) * | 2008-01-31 | 2013-06-21 | Ethypharm Sa | Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine |
| US9072668B2 (en) | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
| US20110223208A1 (en) * | 2010-03-09 | 2011-09-15 | Beth Hill | Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| PT2425814E (pt) * | 2010-09-03 | 2013-09-02 | Novagali Pharma Sa | Emulsão de tipo água em óleo para tratamento de uma doença ocular |
| US9107822B2 (en) | 2010-09-03 | 2015-08-18 | Santen Sas | Water-in oil type emulsion for treating a disease of the eye |
| CA2809460C (fr) * | 2010-09-03 | 2018-12-11 | Novagali Pharma Sa | Emulsion de type eau-dans-l'huile destinee au traitement d'une maladie oculaire |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| EP3468530A4 (fr) | 2016-06-10 | 2020-03-11 | Clarity Cosmetics Inc. | Formulations non comédogènes de soin des cheveux et du cuir chevelu et méthode d'utilisation |
| CN108479649A (zh) * | 2018-05-10 | 2018-09-04 | 哈尔滨工业大学 | 一种有机凝胶的制备方法与应用 |
| WO2023116517A1 (fr) * | 2021-12-24 | 2023-06-29 | 四川科伦药物研究院有限公司 | Préparation d'administration continue pouvant être libérée de manière stable et procédé de préparation associé |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932624A (en) | 1974-06-17 | 1976-01-13 | Morton-Norwich Products, Inc. | Method for prolonging the inhibitory effect of saralasin on angiotensin II |
| US3969087A (en) | 1974-08-07 | 1976-07-13 | Ajinomoto Co., Ltd. | Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents |
| JPS5119139A (ja) * | 1974-08-07 | 1976-02-16 | Ajinomoto Kk | Gerujokeshoryososeibutsu |
| US5575815A (en) | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
| SI9300468A (en) | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
| EP0725620B1 (fr) * | 1993-10-18 | 2001-03-14 | The Procter & Gamble Company | Rouges a levres non exsudants |
| US5968542A (en) | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
| US5702717A (en) | 1995-10-25 | 1997-12-30 | Macromed, Inc. | Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers |
| US20010007673A1 (en) | 1999-11-12 | 2001-07-12 | Merrill Seymour Goldenberg | Sustained-release delayed gels |
| CA2212300A1 (fr) | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | Gelification in vitro ou in vivo du chitosane et utilisations therapeutiques du chitosane |
| BE1011899A6 (fr) | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
| US6306383B1 (en) | 1998-09-16 | 2001-10-23 | Wilson T Crandall | Method for topical treatment of scars with protein kinase C inhibitors |
| FR2794998B1 (fr) * | 1999-06-21 | 2001-07-27 | Oreal | Organogels et leurs utilisations notamment cosmetiques |
| FR2795360B1 (fr) | 1999-06-24 | 2001-12-14 | Technologique De Prec Mecaniqu | Procede de fabrication d'articles de conditionnement et machine de fabrication correspondante |
| JP2005528352A (ja) | 2002-03-12 | 2005-09-22 | エチファルム | 生体活性物質の持続的放出に用いるためのゲル化特性を有する組成物 |
-
2003
- 2003-03-12 JP JP2003574161A patent/JP2005528352A/ja active Pending
- 2003-03-12 EP EP03725281.4A patent/EP1485066B1/fr not_active Expired - Lifetime
- 2003-03-12 BR BRPI0308360A patent/BRPI0308360B8/pt not_active IP Right Cessation
- 2003-03-12 AU AU2003227827A patent/AU2003227827B2/en not_active Ceased
- 2003-03-12 CN CN03810055A patent/CN100584314C/zh not_active Expired - Fee Related
- 2003-03-12 NZ NZ535270A patent/NZ535270A/en not_active IP Right Cessation
- 2003-03-12 CA CA2478825A patent/CA2478825C/fr not_active Expired - Fee Related
- 2003-03-12 US US10/507,281 patent/US7691408B2/en active Active
- 2003-03-12 MX MXPA04008906A patent/MXPA04008906A/es active IP Right Grant
- 2003-03-12 WO PCT/FR2003/000797 patent/WO2003075885A1/fr active Application Filing
-
2004
- 2004-09-12 IL IL164031A patent/IL164031A/en not_active IP Right Cessation
- 2004-10-12 NO NO20044310A patent/NO339426B1/no not_active IP Right Cessation
-
2005
- 2005-06-14 HK HK05104957.8A patent/HK1071704A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1071704A1 (zh) | 2005-07-29 |
| BR0308360A (pt) | 2005-01-25 |
| EP1485066A1 (fr) | 2004-12-15 |
| CN1649567A (zh) | 2005-08-03 |
| BR0308360B1 (pt) | 2017-11-14 |
| US20060121115A1 (en) | 2006-06-08 |
| NZ535270A (en) | 2006-11-30 |
| EP1485066B1 (fr) | 2016-09-21 |
| US7691408B2 (en) | 2010-04-06 |
| BRPI0308360B8 (pt) | 2021-05-25 |
| CN100584314C (zh) | 2010-01-27 |
| NO20044310L (no) | 2004-10-12 |
| CA2478825C (fr) | 2012-01-24 |
| AU2003227827B2 (en) | 2008-09-25 |
| NO339426B1 (no) | 2016-12-12 |
| AU2003227827A1 (en) | 2003-09-22 |
| CA2478825A1 (fr) | 2003-09-18 |
| WO2003075885A1 (fr) | 2003-09-18 |
| JP2005528352A (ja) | 2005-09-22 |
| MXPA04008906A (es) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164031A (en) | Compositiion having gelling properaties for the prolonged delivery of bioactive substances | |
| AU2003222137A1 (en) | Microgel particles for the delivery of bioactive materials | |
| GB2421689B (en) | Drug delivery system | |
| AU2003291103A8 (en) | Pharmaceutical composition | |
| PL376169A1 (en) | Drug delivery system | |
| IL164547A0 (en) | Pharmaceutical composition | |
| HK1076743A1 (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| IL165878A0 (en) | Pharmaceutical composition | |
| SG118275A1 (en) | Polymers for the delivery of bioactive agents and methods of their preparation | |
| IL149377A0 (en) | Pharmaceutical formulation comprising melatonin | |
| AU2003296961A8 (en) | Targeted invitation delivery | |
| HK1065477A1 (en) | Pharmaceutical composition | |
| IL164031A0 (en) | Composition having gelling properaties for the prolonged delivery of bioactive substances | |
| EP1508332A4 (fr) | Composition medicinale | |
| GB0327814D0 (en) | Aerosolisable composition and delivery system | |
| EP1624822A4 (fr) | Nouveaux systemes de distribution de gomme | |
| GB0225827D0 (en) | Medicated comestibles | |
| GB0217703D0 (en) | Pharmaceutical composition | |
| GB0209411D0 (en) | Drug delivery | |
| GB0217478D0 (en) | Multiple-therapy drug delivery | |
| GB0212738D0 (en) | Microspheres for bioactive delivery | |
| SI1467750T1 (sl) | Farmacevtski sestavek perindoprila disperzen v ustih (orodisperzen) | |
| GB0219421D0 (en) | Improvements in or relating to formulations for the delivery of drugs | |
| GB0214491D0 (en) | Pharmaceutical composition | |
| GB0213306D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |